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Abstract The freedom to consent to participate in medical research is a complex subject, particularly in socio-
economically vulnerable communities, where numerous factors may limit the efficacy of the informed
consent process. Informal consultation among members of the Switching the Poles Clinical Research
Network coming from various sub-Saharan African countries, that is Burkina Faso, The Gambia,
Rwanda, Ethiopia, the Democratic Republic of Congo (DRC) and Benin, seems to support the
hypothesis that in socio-economical vulnerable communities with inadequate access to health care,
the decision to participate in research is often taken irrespectively of the contents of the informed
consent interview, and it is largely driven by the opportunity to access free or better quality care and
other indirect benefits. Populations’ vulnerability due to poverty and/or social exclusion should
obviously not lead to exclusion from medical research, which is most often crucially needed to
address their health problems. Nonetheless, to reduce the possibility of exploitation, there is the need
to further investigate the complex links between socio-economical vulnerability, access to health care
and individual freedom to decide on participation in medical research. This needs bringing together
clinical researchers, social scientists and bioethicists in transdisciplinary collaborative research efforts
that require the collective input from researchers, research sponsors and funders.
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Introduction
Ensuring free decision-making when deciding to be part
of medical research is a complex subject, particularly in
socio-economically vulnerable communities. For instance
comprehension, one of the cornerstones of the consent
procedure may be impaired by illiteracy (Chaisson et al.
2011), as well as by a lack of consideration for the local
socio-cultural context when informing potential study
subjects (Tekola et al. 2009; Bull et al. 2012; Vreeman
et al. 2012). But in addition to the information provided
during the consent process, other factors may influence
people’s decision to participate in research, possibly limit-
ing the importance of the informed consent process.
In a recent anthropological study in a semiurban set-
ting in Burkina Faso, Pare Toe et al. (2013) reported that
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most parents of children enrolled in a malaria paediatric
clinical study had taken the decision of participating
before starting the informed consent process. Their indi-
vidual decision was based on information that informally
spread through the community and was mainly motivated
by the possibility of accessing free and good quality
health care during the study period.
The study raises the question whether this also occurs
in other African contexts and trials and how these find-
ings relate to potential risk in research participation and
to free decision-making. We discussed this question
within the Switching the Poles Clinical Research Network
(http://www.itg.be/itg/GeneralSite/Default.aspx?
L=E&WPID=705&MIID=670, last accessed on 17th
August 2014; Tinto et al. 2013). This network brings
together research institutions from South-East Asia, sub-
Saharan Africa and Latin America, with the objective of
developing clinical research policies that are compliant
with appropriate ethical and methodological standards
and that are feasible in resource-constrained settings and
programmes. Since the start of the network’s activities in
2008, the informed consent process in vulnerable popula-
tions was identified as a major challenge by all members,
and this resulted in the Institut de Recherche en Science
de la Sante (IRSS)/Centre Muraz (Burkina Faso) taking
the lead on this topic and carrying out the above-men-
tioned study (Pare Toe et al. 2013).
Besides the IRSS/Centre Muraz, the institutions that
participated in the discussion leading to this manuscript
were the Medical Research Council Unit (The Gambia),
Rinda Ubuzima (Rwanda), the Institute National de
Recherche Biomedicale and the University of Kinshasa
(DRC), the Centre de Recherches Entomologiques de
Cotonou (Benin), the Addis Ababa University School of
Public Health (Ethiopia) and the Institute of Tropical
Medicine (Belgium).
Clinical research and access to medical benefits
All the participating researchers agreed that in settings
with inadequate access to health care, the opportunity of
receiving free medical care is often a strong incentive to
participation in clinical studies and may result in ‘pro-
active strategies’ for being recruited, independent of the
researchers’ best efforts to accurately inform potential
participants and to underline the experimental nature of
the study.
In The Gambia, for instance, exhaustive information
about new trials is carefully ‘cascaded’ through the com-
munity hierarchy. The study is first introduced to the vil-
lage heads (the ‘Alkalo’), who subsequently convey the
information to household heads and religious leaders.
Additional community sensitisation is organised to pro-
vide feedback on findings of previous studies, as well as
to introduce the new trial (Afolabi et al. 2014). Never-
theless, mothers still actively seek to find out whether
their children can be enrolled in any other trials, in order
to increase their chances of obtaining the study-related
benefits (such as better access to care).
During a study on family planning in Rwanda, women
sought out the research site with the specific purpose of
being recruited, even without having attended any infor-
mation sessions in the community or even if knowing
that they did not meet the inclusion criteria. The
women’s willingness to participate seemed to be indepen-
dent of the detailed information they would later receive
during the consent process, as enrolment allowed access
to cervical cancer screening and to free testing and treat-
ment for sexually transmitted infections.
In Ethiopia, researchers observed high levels of implicit
expectation from research at personal and community
level among residents in rural and socio-economically
poor communities. In a recent qualitative assessment con-
ducted in the rural area of Butajira, members of the com-
munity expressed their disappointment about a
prospective cohort study, as part of the community felt
excluded from the benefits allocated to the households
included in the cohort, that is medical and school support
for children. The project data collectors also iterated that
poor rural households tended to consent to participate in
the research more rapidly than those with higher socio-
economic status.
During a prospective cohort clinical study conducted in
lagoon area in Benin, (Nahum et al. 2007) many parents
who had initially refused to consent for their children, at
a later stage reported to the study team, volunteering for
recruitment. The researchers observed that this change of
attitude was linked to the wish to access the free care
benefits provided to recruited children.
In such poor communities, besides the personal bene-
fits, trial participation may be seen as an opportunity for
other family members to access better health care. In a
malaria study conducted in Kinshasa (Muhindo et al.
2013), for instance, some mothers reportedly attempted
to obtain additional concomitant medications for
recruited children, which in reality they intended to use
for some of their sick but not recruited children. The
view of the clinical study as a means to access to health
benefits is echoed by the observations of researchers in
the DRC, who reported a ‘selective recall’ of the
informed consent information: many potential partici-
pants focused on the fact that the study team would
take care of adverse events and medical problems occur-
ring during the study, while they tended to ignore the
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experimental nature and the potential risks attached. In
addition, participants from socio-economically vulnerable
communities, for example Kasa€ı province of DRC, are
reported to decide on trial participation primarily or
solely on the trust they place in their medical caregivers,
that is nurses and doctors, believing they will always
make the best individually tailored decision for them.
Beside the direct medical benefits, monetary reimburse-
ments for the travel to the study clinic for scheduled and
unscheduled study visits also are an incentive for trial
participation, as observed by researchers in Burkina Faso,
Rwanda, Benin, Ethiopia and DRC. In DRC, this also
applied to the reimbursement of food expenses incurred
during a study visit or the period of hospitalisation as
part of the study. Researchers even noticed that some
parents seemed unsatisfied when the trial team
announced that their child had successfully completed the
follow-up, potentially because of the end of the benefits.
Noteworthy, these monetary reimbursements had been
approved – and in some cases explicitly required – by the
concerned Ethics Committees(s) that considered them
fair, that is not representing an undue inducement. The
researchers’ observations, however, show that for individ-
uals and families living in a disadvantaged socio-eco-
nomic situation, they were still an incentive to
participate. From this perspective, trial participation can
be seen as a strategic choice based on a ‘risk-benefit
assessment’ that goes beyond the purely medical and
technical aspects of the research.
Informed consent in vulnerable communities: a way
forward?
Overall, these anecdotal observations in different settings
in sub-Saharan Africa seem to confirm that in socio-eco-
nomically vulnerable communities, the decision to partici-
pate in research is often taken prior to and irrespectively
of the contents of the informed consent interview, and it
is largely driven by the opportunity to access free and/or
better quality care and other indirect benefits.
Populations’ vulnerability due to poverty and/or social
exclusion should not lead to exclusion from medical
research and, as such, research is most often crucially
needed to address their specific health problems. The goal
therefore is to strive for a balance between the risk of
exploitation and the relevance of the research imple-
mented in these populations (Ravinetto et al. 2013). To
reduce the possibility of exploitation, explorative research
is ongoing in our network, addressing certain challenges
related to illiteracy and poor comprehension in the
informed consent process, for example the development of
multimedia tools for delivering the informed consent
information (Afolabi et al. 2014), or of context-adapted
assessments of understanding before confirming enrolment
(Saidu et al. 2013; Afolabi et al. 2014). However, achiev-
ing full comprehension is essential but not sufficient to
secure the freedom to decide, as in many contexts, the
risks related to the research intervention –even if well
explained and well understood – are overshadowed by the
risk of not being included in the research and losing the
related benefits. In other words, for these vulnerable com-
munities, the study-related benefits (including, but not lim-
ited to, free access to quality health care during the study
period) remain a strong incentive to study participation,
irrespective of the accuracy of the informed consent proce-
dure and despite other local cultural concerns (Peeters
Grietens et al. 2014). As suggested, the participation in
the trial becomes a pro-active strategic choice to secure
otherwise unavailable health and non-health resources,
and it is not necessarily based on poor comprehension of
the study risks, but on a ‘risk-benefit assessment’ that
takes into consideration factors other than those usually
considered in the protocol design.
There is therefore the need to further investigate the
complex links between socio-economical vulnerability,
access to health care and individual freedom to decide on
participation in medical research. This goes beyond the
simple improvement of the informed consent procedure
and requires an interdisciplinary approach that includes
clinical researchers, social scientists and bioethicists, as
well as the collective input from researchers, Ethics Com-
mittees, sponsors and funders.
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